Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin A and Nicotinamide in Kidney Transplant Recipients with Skin Cancer History
NCT05702398Phase 1Recruiting
- Sponsor
- Rhode Island Hospital
- Start
- Apr 2023
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in skin cancer comparing Vitamin A & Nicotinamide with Placebo (2 arms). Primary endpoint: Change of Blood Vitamin A and Nicotinamide Levels at 6 months. Started Apr 2023; status: recruiting.
02
Drugs
vitamin anicotinamide
03
Conditions
skin cancer
Beyond the preview
Go deeper on NCT05702398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05702398.